USANA Health Sciences Inc (USNA) Stock Forecast & Price Target
USANA Health Sciences Inc · NYSE
$15.20+0.24 (+1.60%)
15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
ANALYST CONSENSUS0 ratings
No Rating
Strong Buy00%
Buy00%
Hold00%
Sell00%
Strong Sell00%
Analyst rating coverage is not available for USNA yet.
12-MONTH PRICE TARGET
—
Average analyst target vs $15.20 current
Highest Target—
Average Target—
Lowest Target—
USNA analyst recommendation trends
86420
Sep
Oct
Nov
Dec
Jan
Strong BuyBuyHoldSellStrong Sell
RATING
SEP
OCT
NOV
DEC
JAN
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
1
1
1
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
Total
1
1
1
1
1
As of Jan, 0 of 1 firms rate USNA a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
USNA EPS & revenue forecast
EPS · NEXT QUARTER
$0.11
Range $0.11 – $0.11 · 1 analysts · -82% YoY
Next period, 1 analysts expect USANA Health Sciences Inc to earn $0.11 a share (range $0.11 – $0.11), versus $0.60 a year earlier. Full-year consensus is $0.76, growing to $1.77 the year after.
REVENUE · NEXT QUARTER
$217.1M
Range $217.1M – $217.1M · 1 analysts · -4% YoY
Revenue is expected to reach $217.1M (range $217.1M – $217.1M), -4.0% year-over-year. Full-year consensus is $909.6M, rising to $949.8M next year.
Top analysts covering USANA Health Sciences Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on USNA.
#1
Linda Bolton Weiser
DA Davidson · Rank #393
Hold
$36.00+136.8% to target
Overall win rate
29%
+ Follow
#2
AL
Anthony Lebiedzinski
Sidoti & Co.
Hold
$39.00+156.6% to target
Coverage
—
+ Follow
USNA stock forecast FAQ
Who is the most accurate analyst covering USNA?+
Among analysts who currently cover USNA, Linda Bolton Weiser of DA Davidson has the strongest overall Quantellect track record (Rank #393). Their current call is Hold with a $36.00 target.
What is USANA Health Sciences Inc's projected EPS for next quarter?+
The consensus estimate is $0.11 per share (range $0.11 – $0.11) across 1 analysts. Full-year EPS is projected at $0.76, rising to $1.77 the following year.
How much revenue is USANA Health Sciences Inc expected to report next quarter?+
Consensus revenue is $217.1M (range $217.1M – $217.1M). Full-year revenue is projected at $909.6M, growing to $949.8M next year.
Have analysts been upgrading or downgrading USNA lately?+
As of Jan, 0 of 1 firms rate USNA a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their USNA calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
